Local Study of Akatinol Memantine in VaD in Russia

See also
Status	Clinical Trial	Phase
Completed	`NCT04567745` - Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers	Phase 1
Recruiting	`NCT04109963` - Trial of Remote Ischemic Pre-conditioning in Vascular Cognitive Impairment	Phase 2
Recruiting	`NCT04335994` - ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing	N/A
Completed	`NCT01761227` - Efficacy and Safety of Fufangdanshen Tablets in Mild to Moderate Vascular Dementia	Phase 2
Active, not recruiting	`NCT01208675` - The Swedish BioFINDER Study
Completed	`NCT00165763` - Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia	Phase 4
Completed	`NCT00621647` - Seroquel- Agitation Associated With Dementia	Phase 3
Recruiting	`NCT04095962` - Effects of a Multicomponent Exercise Intervention on Physical and Cognitive Function of Older Adults With Dementia	N/A
Recruiting	`NCT03275363` - The University of Hong Kong Neurocognitive Disorder Cohort	N/A
Active, not recruiting	`NCT03804229` - Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia	Phase 3
Enrolling by invitation	`NCT03724136` - Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study	N/A
Completed	`NCT02453932` - Efficacy and Safety of Tianzhi Granule in Mild to Moderate Vascular Dementia	Phase 3
Completed	`NCT00947531` - A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia	Phase 4
Not yet recruiting	`NCT03702543` - Managing Vascular Dementia Risk Factors With SymTrend	Phase 1
Enrolling by invitation	`NCT02147652` - Personalized Music Therapy and Agitation in Dementia	N/A
Recruiting	`NCT04114994` - Longitudinal Cognitive Assessment by BoCA
Recruiting	`NCT06034509` - Cognitive and Vascular Functioning Following TBI
Recruiting	`NCT05921266` - Urolithin A Supplementation in Middle-aged Adults With Obesity	N/A
Not yet recruiting	`NCT01466543` - Effect of Zydena (Udenafil) on Cerebral Blood Flow and Peripheral Blood Viscosity	Phase 2
Completed	`NCT01465360` - Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center	N/A

NCT number	NCT03986424
Study type	Interventional
Source	Merz Pharmaceuticals GmbH
Contact
Status	Completed
Phase	Phase 3
Start date	January 23, 2018
Completion date	June 1, 2022

Local Study of Akatinol Memantine in VaD in Russia — MIND

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms